{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:00:35Z","timestamp":1790870435863,"version":"4.1.0"},"reference-count":140,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CaRiPaRo Foundation Excellence Research Project 2018\u2014BPiTA","award":["52012"],"award-info":[{"award-number":["52012"]}]},{"name":"CaRiPaRo Foundation Excellence Research Project 2018\u2014BPiTA","award":["ACQU_SID19_01"],"award-info":[{"award-number":["ACQU_SID19_01"]}]},{"DOI":"10.13039\/501100003500","name":"University of Padua","doi-asserted-by":"publisher","award":["52012"],"award-info":[{"award-number":["52012"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"University of Padua","doi-asserted-by":"publisher","award":["ACQU_SID19_01"],"award-info":[{"award-number":["ACQU_SID19_01"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Amyloidoses are a group of diseases associated with deposits of amyloid fibrils in different tissues. So far, 36 different types of amyloidosis are known, each due to the misfolding and accumulation of a specific protein. Amyloid deposits can be found in several organs, including the heart, brain, kidneys, and spleen, and can affect single or multiple organs. Generally, amyloid-forming proteins become prone to aggregate due to genetic mutations, acquired environmental factors, excessive concentration, or post-translational modifications. Interestingly, amyloid aggregates are often composed of proteolytic fragments, derived from the degradation of precursor proteins by yet unidentified proteases, which display higher amyloidogenic tendency compared to precursor proteins, thus representing an important mechanism in the onset of amyloid-based diseases. In the present review, we summarize the current knowledge on the proteolytic susceptibility of three of the main human amyloidogenic proteins, i.e., transthyretin, \u03b2-amyloid precursor protein, and \u03b1-synuclein, in the onset of amyloidosis. We also highlight the role that proteolytic enzymes can play in the crosstalk between intestinal inflammation and amyloid-based diseases.<\/jats:p>","DOI":"10.3390\/ijms24010699","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T04:07:09Z","timestamp":1672632429000},"page":"699","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Role of Proteolysis in Amyloidosis"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-0871","authenticated-orcid":false,"given":"Laura","family":"Acquasaliente","sequence":"first","affiliation":[{"name":"Laboratory of Protein Chemistry and Molecular Hematology, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9775-8894","authenticated-orcid":false,"given":"Vincenzo","family":"De Filippis","sequence":"additional","affiliation":[{"name":"Laboratory of Protein Chemistry and Molecular Hematology, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrneph.2013.171","article-title":"Pathophysiology and treatment of systemic amyloidosis","volume":"9","author":"Gillmore","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular Mechanisms of Amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein Misfolding, Functional Amyloid, and Human Disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: Update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and Management of the Cardiac Amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506129.2011.571319","article-title":"Myocardial infarction with \u201cclean coronaries\u201d caused by amyloid light-chain AL amyloidosis: A case report and literature review","volume":"18","author":"Tsai","year":"2011","journal-title":"Amyloid"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-Associated Kidney Disease","volume":"17","author":"Dember","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4065\/83.11.1226","article-title":"Patterns of Neuropathy and Autonomic Failure in Patients with Amyloidosis","volume":"83","author":"Wang","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2002-25304","article-title":"Pulmonary and Tracheobronchial Amyloidosis","volume":"23","author":"Berk","year":"2002","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-200003000-00001","article-title":"Tracheobronchial Amyloidosis: The Boston University Experience from 1984 to 1999","volume":"79","author":"Fenlon","year":"2000","journal-title":"Medicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The Amyloid State of Proteins in Human Diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1021\/acs.jproteome.1c00424","article-title":"Multiplex Mass Spectrometry Analysis of Amyloid Proteins in Human Plasma for Alzheimer\u2019s Disease Diagnosis","volume":"20","author":"Ni","year":"2021","journal-title":"J. Proteome Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nchem.945","article-title":"Ion mobility-mass spectrometry reveals a conformational conversion from random assembly to \u03b2-sheet in amyloid fibril formation","volume":"3","author":"Bleiholder","year":"2011","journal-title":"Nat. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3181\/00379727-131-34110","article-title":"Characterization of the Amyloid Fibril as a Cross-beta Protein","volume":"131","author":"Bonar","year":"1969","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"18349","DOI":"10.1073\/pnas.0806270105","article-title":"Molecular structural basis for polymorphism in Alzheimer\u2019s \u03b2-amyloid fibrils","volume":"105","author":"Paravastu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1126\/science.1151839","article-title":"Amyloid Fibrils of the HET-s(218\u2013289) Prion Form a \u03b2 Solenoid with a Triangular Hydrophobic Core","volume":"319","author":"Wasmer","year":"2008","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","article-title":"Techniques to study amyloid fibril formation in vitro","volume":"34","author":"Nilsson","year":"2004","journal-title":"Methods"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/19336896.2019.1704612","article-title":"Proteinase K resistant cores of prions and amyloids","volume":"14","author":"Kushnirov","year":"2020","journal-title":"Prion"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1073\/pnas.91.12.5602","article-title":"Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure","volume":"91","author":"Pepys","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(00)01530-1","article-title":"Molecular chaperone properties of serum amyloid P component","volume":"473","author":"Coker","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","article-title":"Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis","volume":"92","author":"Tennent","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2796.1992.tb00628.x","article-title":"Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition","volume":"232","author":"Kisilevsky","year":"1992","journal-title":"J. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.1178250","article-title":"An Analytical Solution to the Kinetics of Breakable Filament Assembly","volume":"326","author":"Knowles","year":"2009","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1039\/C4CP05563B","article-title":"On the lag phase in amyloid fibril formation","volume":"17","author":"Arosio","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbapap.2008.10.016","article-title":"Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature","volume":"1794","author":"Morris","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) Proteins Proteom."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"Bucciantini","year":"2002","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/19336896.2018.1521234","article-title":"Proteolysis: A double-edged sword for the development of amyloidoses","volume":"12","author":"Okamoto","year":"2018","journal-title":"Prion"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15252\/emmm.201505357","article-title":"A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis","volume":"7","author":"Marcoux","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/path.2607","article-title":"Fibril protein fragmentation pattern in systemic AL-amyloidosis","volume":"219","author":"Enqvist","year":"2009","journal-title":"J. Pathol."},{"key":"ref_32","first-page":"5497046","article-title":"Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress","volume":"2020","author":"Tramutola","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0305-0491(96)00212-X","article-title":"The Evolution of Gene Expression, Structure and Function of Transthyretin","volume":"116","author":"Schreiber","year":"1997","journal-title":"Comp. Biochem. Physiol. Part B Biochem. Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.1021\/bi051608t","article-title":"The Pathway by Which the Tetrameric Protein Transthyretin Dissociates","volume":"44","author":"Foss","year":"2005","journal-title":"Biochemistry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0022-2836(71)90218-X","article-title":"An X-ray study of the subunit structure of prealbumin","volume":"61","author":"Blake","year":"1971","journal-title":"J. Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/PL00000791","article-title":"Transthyretin: A review from a structural perspective","volume":"58","author":"Hamilton","year":"2001","journal-title":"Cell Mol. Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mus.26034","article-title":"Estimating the global prevalence of transthyretin familial amyloid polyneuropathy","volume":"57","author":"Schmidt","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: A model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1073\/pnas.1317488111","article-title":"Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis","volume":"111","author":"Mangione","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/10408369409084679","article-title":"Amyloidosis","volume":"31","author":"Sipe","year":"1994","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.261419998","article-title":"The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis","volume":"98","author":"Jiang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e004000","DOI":"10.1161\/CIRCHEARTFAILURE.117.004000","article-title":"Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin","volume":"11","author":"Hanson","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"28932","DOI":"10.1074\/jbc.M115.659912","article-title":"Uncovering the Mechanism of Aggregation of Human Transthyretin","volume":"290","author":"Saelices","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/13506129.2013.797890","article-title":"Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis","volume":"20","author":"Ihse","year":"2013","journal-title":"Amyloid"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.1759","article-title":"Amyloid deposits in transthyretin-derived amyloidosis: Cleaved transthyretin is associated with distinct amyloid morphology","volume":"206","author":"Gustavsson","year":"2005","journal-title":"J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/13506120600877003","article-title":"Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis","volume":"13","author":"Liepnieks","year":"2006","journal-title":"Amyloid"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/TP.0b013e31824b3749","article-title":"Amyloid Fibril Composition as a Predictor of Development of Cardiomyopathy After Liver Transplantation for Hereditary Transthyretin Amyloidosis","volume":"93","author":"Gustafsson","year":"2012","journal-title":"Transplantation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.RA118.003990","article-title":"Plasminogen activation triggers transthyretin amyloidogenesis in vitro","volume":"293","author":"Mangione","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/j.1460-2075.1993.tb05708.x","article-title":"Modifications of transthyretin in amyloid fibrils: Analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation","volume":"12","author":"Wahlqvist","year":"1993","journal-title":"EMBO J."},{"key":"ref_51","first-page":"772","article-title":"Purification and Characterization of Amyloid-Related Transthyretin Associated with Familial Amyloidotic Cardiomyopathy","volume":"227","author":"Hermansen","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"15161","DOI":"10.1074\/jbc.M117.795245","article-title":"Non-canonical proteolytic activation of human prothrombin by subtilisin from Bacillus subtilis may shift the procoagulant-anticoagulant equilibrium toward thrombosis","volume":"292","author":"Pontarollo","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s42003-020-01493-0","article-title":"A serine protease secreted from Bacillus subtilis cleaves human plasma transthyretin to generate an amyloidogenic fragment","volume":"3","author":"Peterle","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.1000097107","article-title":"Composition, variability, and temporal stability of the intestinal microbiota of the elderly","volume":"108","author":"Claesson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100938","DOI":"10.1016\/j.arr.2019.100938","article-title":"Intestinal epithelial barrier functions in ageing","volume":"54","author":"Branca","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Da Costa, G., Ribeiro-Silva, C., Ribeiro, R., Gilberto, S., Gomes, R.A., Ferreira, A., Mateus, \u00c9., Barroso, E., Coelho, A.V., and Freire, A.P. (2015). Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125392"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/gut.21.7.580","article-title":"Metabolism of 125I-labelled trypsin in man: Evidence of recirculation","volume":"21","author":"Rubio","year":"1980","journal-title":"Gut"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Midtvedt, T., Zabarovsky, E., Norin, E., Bark, J., Gizatullin, R., Kashuba, V., Ljungqvist, O., Zabarovska, V., M\u00f6llby, R., and Ernberg, I. (2013). Increase of Faecal Tryptic Activity Relates to Changes in the Intestinal Microbiome: Analysis of Crohn\u2019s Disease with a Multidisciplinary Platform. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066074"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14425","DOI":"10.1074\/jbc.M117.786657","article-title":"Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones","volume":"292","author":"Constantinescu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1046\/j.1471-4159.2000.0752172.x","article-title":"Tissue Plasminogen Activator Requires Plasminogen to Modulate Amyloid-\u03b2 Neurotoxicity and Deposition","volume":"75","author":"Tucker","year":"2000","journal-title":"J. Neurochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2000.02183.x","article-title":"Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis","volume":"110","author":"Mumford","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1538-7836.2007.02457.x","article-title":"Increased plasmin-\u03b12-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses","volume":"5","author":"Bouma","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13506120902879269","article-title":"Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cells","volume":"16","author":"Uchiba","year":"2009","journal-title":"Amyloid"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","article-title":"Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein","volume":"26","author":"Priller","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","article-title":"Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory","volume":"70","author":"Turner","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"Iron-Export Ferroxidase Activity of \u03b2-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer\u2019s Disease","volume":"142","author":"Duce","year":"2010","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.mp.4000552","article-title":"It all sticks together\u2014The APP-related family of proteins and Alzheimer\u2019s disease","volume":"4","author":"Bayer","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","article-title":"The genetic architecture of Alzheimer\u2019s disease: Beyond APP, PSENs and APOE","volume":"33","author":"Guerreiro","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.conb.2004.05.010","article-title":"The \u03b3-secretase complex: Machinery for intramembrane proteolysis","volume":"14","author":"Iwatsubo","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/bies.201400116","article-title":"Golgi defects enhance APP amyloidogenic processing in Alzheimer\u2019s disease","volume":"37","author":"Joshi","year":"2015","journal-title":"BioEssays"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1074\/jbc.M113.498246","article-title":"Characterization of Intermediate Steps in Amyloid Beta (A\u03b2) Production under Near-native Conditions","volume":"289","author":"Olsson","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","article-title":"Gamma-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of beta-Carboxyl Terminal Fragment","volume":"29","author":"Takami","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/74656","article-title":"A second cytotoxic proteolytic peptide derived from amyloid \u03b2-protein precursor","volume":"6","author":"Lu","year":"2000","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1471-4159.2011.07519.x","article-title":"Proteolytic processing of Alzheimer\u2019s \u03b2-amyloid precursor protein","volume":"120","author":"Zhang","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/bbrc.2000.3051","article-title":"Oligomerization and Toxicity of \u03b2-Amyloid-42 Implicated in Alzheimer\u2019s Disease","volume":"273","author":"Mahil","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.nbd.2004.08.002","article-title":"Coordinated and widespread expression of \u03b3-secretase in vivo: Evidence for size and molecular heterogeneity","volume":"17","author":"Serneels","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbrc.2004.11.130","article-title":"Expression profiles of two human APH-1 genes and their roles in formation of presenilin complexes","volume":"327","author":"Saito","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1073\/pnas.052436599","article-title":"Activity-dependent isolation of the presenilin\u2013\u03b3-secretase complex reveals nicastrin and a \u03b3-secretase substrate","volume":"99","author":"Esler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/35015085","article-title":"Photoactivated \u03b3-secretase inhibitors directed to the active site covalently label presenilin 1","volume":"405","author":"Li","year":"2000","journal-title":"Nature"},{"key":"ref_81","first-page":"428","article-title":"Transition-state analogue inhibitors of \u03b3-secretase bind directly to presenilin-1","volume":"2","author":"Esler","year":"2000","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ncl.2007.03.009","article-title":"Genetics of Alzheimer\u2019s Disease: A Centennial Review","volume":"25","year":"2007","journal-title":"Neurol. Clin."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/1871527313666140917112248","article-title":"Protein Interactions Between the C-Terminus of A\u03b2-Peptide and Phospholipase A2\u2014A Structure Biology Based Approach to Identify Novel Alzheimer\u2019s Therapeutics","volume":"13","author":"Mirza","year":"2014","journal-title":"CNS Neurol. Disord.\u2014Drug Targets"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tcb.2017.02.002","article-title":"\u03b1-Synuclein\u2014Regulator of Exocytosis, Endocytosis, or Both?","volume":"27","author":"Kaminski","year":"2017","journal-title":"Trends Cell Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1074\/jbc.M109541200","article-title":"Biophysical Properties of the Synucleins and Their Propensities to Fibrillate: Inhibition of alpha-synuclein assembly by beta- and gamma-synucleins","volume":"277","author":"Uversky","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature16531","article-title":"Structural disorder of monomeric \u03b1-synuclein persists in mammalian cells","volume":"530","author":"Theillet","year":"2016","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"\u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: A cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of \u03b1-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"Salem","year":"2006","journal-title":"FASEB J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.1038\/s41598-022-12886-y","article-title":"Exogenous human \u03b1-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting \u03b1-thrombin-induced platelet activation","volume":"12","author":"Acquasaliente","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of \u03b1-Synuclein Secondary Structure upon Binding to Synthetic Membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1073\/pnas.1505953112","article-title":"KTKEGV repeat motifs are key mediators of normal \u03b1-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity","volume":"112","author":"Dettmer","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"13322","DOI":"10.1021\/bi7014053","article-title":"Role of Different Regions of \u03b1-Synuclein in the Assembly of Fibrils","volume":"46","author":"Qin","year":"2007","journal-title":"Biochemistry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of \u03b1-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/1074-5521(95)90071-3","article-title":"The core Alzheimer\u2019s peptide NAC forms amyloid fibrils which seed and are seeded by \u03b2-amyloid: Is NAC a common trigger or target in neurodegenerative disease?","volume":"2","author":"Han","year":"1995","journal-title":"Chem. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A\u03b2 component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"\u03b1-Synuclein Fibrillogenesis Is Nucleation-dependent. Implications for the pathogenesis of Parkinson\u2019s disease","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.03-0338rev","article-title":"\u03b1-Synuclein and Parkinson\u2019s disease","volume":"18","author":"Recchia","year":"2004","journal-title":"FASEB J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: From structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","article-title":"The emerging role of \u03b1-synuclein truncation in aggregation and disease","volume":"295","author":"Sorrentino","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","article-title":"Ubiquitin signalling in neurodegeneration: Mechanisms and therapeutic opportunities","volume":"28","author":"Schmidt","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.molmed.2020.07.004","article-title":"Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism","volume":"26","author":"Tayebi","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"24862","DOI":"10.1074\/jbc.M112.348128","article-title":"Proteolytic Cleavage of Extracellular \u03b1-Synuclein by Plasmin: Implications for Parkinson disease","volume":"287","author":"Kim","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/hmg\/ddg283","article-title":"Alpha-synuclein degradation by serine protease neurosin: Implication for pathogenesis of synucleinopathies","volume":"12","author":"Iwata","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"14168","DOI":"10.1074\/jbc.M111.222430","article-title":"Role of Matrix Metalloproteinase 3-mediated \u03b1-Synuclein Cleavage in Dopaminergic Cell Death","volume":"286","author":"Choi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M503341200","article-title":"Proteolytic Cleavage of Extracellular Secreted \u03b1-Synuclein via Matrix Metalloproteinases","volume":"280","author":"Sung","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1471-4159.2003.01878.x","article-title":"Distinct cleavage patterns of normal and pathologic forms of \u03b1-synuclein by calpain I in vitro","volume":"86","author":"Guttmann","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1074\/mcp.M115.053413","article-title":"Predictions of Cleavability of Calpain Proteolysis by Quantitative Structure-Activity Relationship Analysis Using Newly Determined Cleavage Sites and Catalytic Efficiencies of an Oligopeptide Array","volume":"15","author":"Koyama","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1460-9568.2007.05736.x","article-title":"Oxidative stress-induced phosphorylation, degradation and aggregation of \u03b1-synuclein are linked to upregulated CK2 and cathepsin D","volume":"26","author":"Takahashi","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.1500937112","article-title":"Cysteine cathepsins are essential in lysosomal degradation of \u03b1-synuclein","volume":"112","author":"McGlinchey","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/abbs\/gmp031","article-title":"The lysosome and neurodegenerative diseases","volume":"41","author":"Zhang","year":"2009","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"16419","DOI":"10.1073\/pnas.212527999","article-title":"Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases","volume":"99","author":"Chiti","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"16052","DOI":"10.1073\/pnas.252340199","article-title":"De novo designed peptide-based amyloid fibrils","volume":"99","author":"Goldie","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nsb752","article-title":"Kinetic partitioning of protein folding and aggregation","volume":"9","author":"Chiti","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"9907","DOI":"10.1073\/pnas.160086297","article-title":"Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: A structural clue to amyloid assembly","volume":"97","author":"Otzen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1110\/ps.33201","article-title":"Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residues","volume":"10","author":"Schwartz","year":"2001","journal-title":"Protein Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"11211","DOI":"10.1073\/pnas.96.20.11211","article-title":"De novo amyloid proteins from designed combinatorial libraries","volume":"96","author":"West","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jmb.2005.04.016","article-title":"Prediction of \u201cAggregation-prone\u201d and \u201cAggregation-susceptible\u201d Regions in Proteins Associated with Neurodegenerative Diseases","volume":"350","author":"Pawar","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Emily, M., Talvas, A., and Delamarche, C. (2013). MetAmyl: A METa-Predictor for AMYLoid Proteins. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079722"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics","volume":"299","author":"Wiseman","year":"2003","journal-title":"Science"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1021\/ar050017s","article-title":"Conformational Change and Assembly through Edge \u03b2 Strands in Transthyretin and Other Amyloid Proteins","volume":"39","author":"Laidman","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1074\/jbc.M310605200","article-title":"Probing Solvent Accessibility of Transthyretin Amyloid by Solution NMR Spectroscopy","volume":"279","author":"Olofsson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jmb.2003.11.008","article-title":"Mapping A\u03b2 Amyloid Fibril Secondary Structure Using Scanning Proline Mutagenesis","volume":"335","author":"Williams","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"16742","DOI":"10.1073\/pnas.262663499","article-title":"A structural model for Alzheimer\u2019s \u03b2-amyloid fibrils based on experimental constraints from solid state NMR","volume":"99","author":"Petkova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"40810","DOI":"10.1074\/jbc.M205659200","article-title":"Structural and Dynamic Features of Alzheimer\u2019s A\u03b2 Peptide in Amyloid Fibrils Studied by Site-directed Spin Labeling","volume":"277","author":"Milton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nsb1195-990","article-title":"Structural model for the \u03b2-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide","volume":"2","author":"Lansbury","year":"1995","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"15871","DOI":"10.1073\/pnas.0506109102","article-title":"Molecular-level secondary structure, polymorphism, and dynamics of full-length \u03b1-synuclein fibrils studied by solid-state NMR","volume":"102","author":"Heise","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1074\/jbc.M110551200","article-title":"Biochemical Characterization of the Core Structure of \u03b1-Synuclein Filaments","volume":"277","author":"Miake","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"37530","DOI":"10.1074\/jbc.M305266200","article-title":"Structural Organization of \u03b1-Synuclein Fibrils Studied by Site-directed Spin Labeling","volume":"278","author":"Jao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1021\/acschemneuro.8b00052","article-title":"Pulsed Hydrogen\u2013Deuterium Exchange Illuminates the Aggregation Kinetics of \u03b1-Synuclein, the Causative Agent for Parkinson\u2019s Disease","volume":"9","author":"Rempel","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1016\/S1359-0278(97)00010-2","article-title":"Probing the partly folded states of proteins by limited proteolysis","volume":"2","author":"Fontana","year":"1997","journal-title":"Fold. Des."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1038\/s41467-021-27416-z","article-title":"Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis","volume":"12","author":"Slamova","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bmcl.2018.12.049","article-title":"New evolutions in the BACE1 inhibitor field from 2014 to 2018","volume":"29","author":"Hsiao","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12715","article-title":"Function, therapeutic potential and cell biology of BACE proteases: Current status and future prospects","volume":"130","author":"Vassar","year":"2014","journal-title":"J. Neurochem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s40265-018-0968-5","article-title":"Inotersen: First Global Approval","volume":"78","author":"Keam","year":"2018","journal-title":"Drugs"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: First Global Approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fnagi.2019.00064","article-title":"Affibody-Mediated Sequestration of Amyloid \u03b2 Demonstrates Preventive Efficacy in a Transgenic Alzheimer\u2019s Disease Mouse Model","volume":"11","author":"Boutajangout","year":"2019","journal-title":"Front. Aging Neurosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/699\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:48:56Z","timestamp":1760147336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24010699"],"URL":"https:\/\/doi.org\/10.3390\/ijms24010699","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,31]]}}}